AAAAAA
Results:
1-13
|
Results: 13
Authors:
Bertrand, E
Brouillet, E
Caille, I
Bouillot, C
Cole, GM
Prochiantz, A
Allinquant, B
Citation: E. Bertrand et al., A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo, MOL CELL NE, 18(5), 2001, pp. 503-511
Authors:
El Massioui, N
Ouary, S
Cheruel, F
Hantraye, P
Brouillet, E
Citation: N. El Massioui et al., Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid, EXP NEUROL, 172(1), 2001, pp. 172-181
Authors:
Mittoux, V
Joseph, JM
Conde, F
Palfi, S
Dautry, C
Poyot, T
Bloch, J
Deglon, N
Ouary, S
Nimchinsky, EA
Brouillet, E
Hof, PR
Peschanski, M
Aebischer, P
Hantraye, P
Citation: V. Mittoux et al., Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease, HUM GENE TH, 11(8), 2000, pp. 1177-1187
Authors:
Kowall, NW
Hantraye, P
Brouillet, E
Beal, MF
McKee, AC
Ferrante, RJ
Citation: Nw. Kowall et al., MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons, NEUROREPORT, 11(1), 2000, pp. 211-213
Authors:
Brouillet, E
Peschanski, M
Hantraye, P
Citation: E. Brouillet et al., Toward understanding the molecular pathology of Huntington's disease, M S-MED SCI, 16(1), 2000, pp. 57-63
Authors:
Ouary, S
Bizat, N
Altairac, S
Menetrat, H
Mittoux, V
Conde, F
Hantraye, P
Brouillet, E
Citation: S. Ouary et al., Major strain differences in response to chronic systemic administration ofthe mitochondrial toxin 3-nitropropionic acid in rats: Implications for neuroprotection studies, NEUROSCIENC, 97(3), 2000, pp. 521-530
Authors:
Dautry, W
Vaufrey, F
Brouillet, E
Bizat, N
Henry, PG
Conde, F
Bloch, G
Hantraye, P
Citation: W. Dautry et al., Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid, J CEREBR B, 20(5), 2000, pp. 789-799
Authors:
Brouillet, E
Hantraye, P
Beal, MF
Citation: E. Brouillet et al., Systemic administration of 3-nitropropionic acid - A new model of Huntington's disease in rat, CONT NEUROS, 2000, pp. 301-332
Authors:
Hantraye, P
Palfi, S
Mittoux, V
Dautry, C
Conde, F
Brouillet, E
Citation: P. Hantraye et al., Replicating Huntington disease's phenotype in nonhuman primates, CONT NEUROS, 2000, pp. 333-353
Authors:
Dautry, C
Conde, F
Brouillet, E
Mittoux, V
Beal, MF
Bloch, G
Hantraye, P
Citation: C. Dautry et al., Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid, NEUROBIOL D, 6(4), 1999, pp. 259-268
Authors:
Brouillet, E
Conde, F
Beal, MF
Hantraye, P
Citation: E. Brouillet et al., Replicating Huntington's disease phenotype in experimental animals, PROG NEUROB, 59(5), 1999, pp. 427-468
Authors:
Brouillet, E
Trembleau, A
Galanaud, D
Volovitch, M
Bouillot, C
Valenza, C
Prochiantz, A
Allinquant, B
Citation: E. Brouillet et al., The amyloid precursor protein interacts with G(o) heterotrimeric protein within a cell compartment specialized in signal transduction, J NEUROSC, 19(5), 1999, pp. 1717-1727
Authors:
Ferrante, RJ
Hantraye, P
Brouillet, E
Beal, MF
Citation: Rj. Ferrante et al., Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase, BRAIN RES, 823(1-2), 1999, pp. 177-182
Risultati:
1-13
|